Posted On: 03/17/2015 8:14:50 PM
Post# of 30015
Clearly the authors of this article don't understand that every pre-revenue company includes the Safe Harbor warning in their filings, and that Amarantus has been a development-stage biotech since its inception.
They probably haven't bothered to look at the development pipeline either.
They probably haven't bothered to look at the development pipeline either.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)